Skip to main content

Sidebar

Main Menu

Home
Highlights
Research
Press Releases
News Reports
Press Room
Staff Awards

Quicklinks

NUS Home
Email
Library
Student
Staff
Alumni

NUS Home
Email
Library
Student
Staff
Alumni

Home
Highlights
Research
Press Releases
News Reports
Press Room
Staff Awards

twitter share quote

02

July

2020

|

15:05

Asia/Singapore

Biotech firm Carmine Therapeutics inks US$900m deal with Takeda Pharmaceutical

The Business Times, 2 July 2020, p16

Newsroom

Share this page

Biotech firm Carmine Therapeutics inks US$900m deal with Takeda Pharmaceutical

Share on: Twitter

Share on: Facebook

Share on: LinkedIn

Follow us on

Visit our Facebook page (opens in new window)
Follow us on X (opens in new window)
(opens in new window)
Visit our LinkedIn page (opens in new window)
Visit our Youtube profile (opens in new window)
(opens in new window)
(opens in new window)

Latest news

16

Apr

2024

-

Clones, drones and visual culture: Teaching the human condition in the 21st century

15

Apr

2024

-

A magnetic butterfly poised to advance quantum technologies

12

Apr

2024

-

NUS scientists uncover a missing link between poor diet and higher cancer risk

11

Apr

2024

-

NUS and NTU again ranked as top Asian universities based on subjects

11

Apr

2024

-

Protection from COVID-19 vaccines wanes faster among elderly: NUS stud

11

Apr

2024

-

Tan Chong Meng: Singapore focuses more on synergies generated by the maritime support industry

National University of Singapore

21 Lower Kent Ridge Road
Singapore 119077
+65 6516 6666

© National University of Singapore. All Rights Reserved.

Legal
Branding guidelines
Contact us
中文

Privacy Notice

This site uses cookies. By clicking accept or continuing to use this site, you agree to our use of cookies. For more details about cookies and how to manage them, please see our Privacy Notice.